Teva Pharmaceuticals Industries Limited

Submit Your Information

Company Name	Teva Pharmaceuticals Industries Limited
Stock Symbol	TEVA
Class Period	October 29, 2015 to August 18, 2020
Lead Plaintiff Motion Deadline	October 23, 2020

On August 18, 2020, the U.S. Department of Justice (“DOJ”) announced that it had filed a complaint against Teva under the False Claim Act, alleging that, from 2007 through 2015, Teva paid certain foundations “with the intent and understanding that they would use Teva’s money to cover the Medicare co-pays of patients taking Copaxone.” The DOJ further stated that during this period “Teva raised the price of Copaxone from approximately $17,000 per year to over $73,000 per year.”

On this news, Teva’s American Depositary Receipt (“ADR”) price fell $1.11 per share, or over 9%, to close at $10.48 per ADR on August 18, 2020, thereby injuring investors.

Submit Your Information

If you suffered a loss on your Teva Pharmaceuticals Industries Limited investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before October 29, 2015?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments